Growth hormone therapy can induce insulin resistance, elevate fasting glucose, worsen glycemic control in diabetics or pre-diabetics, increase risk of developing type 2 diabetes with long-term use, and require medication adjustments for individuals with existing diabetes
Typical examples of anti-GLP-1 injections used for weight loss include: Semaglutide, a GLP-1 receptor agonist that works by reducing appetite and improving satiety Liraglutide, a daily injectable GLP-1 analogue commonly prescribed for long-term weight management Tirzepatide, a dual GIP and GLP-1 receptor agonist that is often used off-label for weight loss and may offer enhanced benefits compared to traditional GLP-1 agonists by targeting multiple metabolic pathways
Athletes who routinely use ibuprofen after training may experience reduced muscle adaptation over time
After injecting, apply gentle pressure with a clean cotton swab
Think of collagen as the steel beams in a building and elastin as the springs that absorb movement